Call for Technology Transfer Offices and Entrepreneurship Support Providers

EIT Health invites consortia composed of two Technology Transfer Offices and one Entrepreneurship Support Provider to deliver components of the Beyond the Lab: From Research to Venture six-month venture building programme for researcher teams; eligible consortia must demonstrate technology transfer and venture building capacity. The call is implemented as cascade funding with a total envelope of €154,000, an expected participation duration of 24 months, an opening date of 02 September 2026 and a single-stage deadline of 02 November 2026 at 16:00 Brussels time. Funded activities include masterclasses, structured mentoring and a final Pitch Day to support incorporation and investor readiness of healthcare start-ups. Selection involves admissibility checks, an online pitching session, an Ethical, Legal and Social Issues review and external expert evaluation with a minimum score threshold of 70/100 for funding consideration.

High-level summary

What the call funds

Grants to consortia to deliver the Beyond the Lab:From Research to Venture programme: six-month venture building activities (masterclasses, structured mentoring and Pitch Day) for researcher teams aiming to incorporate healthcare start-ups.

Who can apply:Consortia composed of two Technology Transfer Offices (from higher education or research organisations) plus one Entrepreneurship Support Provider (venture builders, incubators, accelerators or similar) with demonstrated venture-building experience.

1. 1Call opens: 02 September 2026
2. 2Deadline: 02 November 2026, 16:00 Brussels time
3. 3Expected duration of participation: 24 months
4. 4Eligibility notification: 06 November 2026
5. 5Applicants must register on the EU Funding & Tender portal (obtain PIC) and apply via EIT Health application platform

Funding available:Total call budget €154,000. Individual award amounts and allocation are defined in the official call documents ¹.

Selection is single-stage with admissibility checks, online pitching sessions and an Ethical, Legal and Social Issues review. Applications must score at least 70/100 to be considered for funding; final decisions combine evaluator scores and EIT Health management priorities.

Apply via the EU Funding & Tenders portal and EIT Health application platform; information sessions and Q&A dates are listed in the call documents.

Footnotes

1. 1Official call documents and application platform links are available on the EU Funding & Tenders Portal listing for this opportunity Call page.

Key facts and administrative data

Call identifier:HORIZON-EIT. Project acronym: EIT Health 26-28. Full name of EU funded project: EIT Health Business Plan 2026-2028. Grant agreement number: 101269968. Total funding available for this call: €154,000. Expected duration of participation for selected providers: 24 months. Opening date: 2 September 2026. Deadline (single-stage): 2 November 2026, 16:00 Brussels time. This call is part of the EIT Health Business Plan 2026 programme and is implemented as cascade funding to external providers.

Primary objective:To select a consortium of Technology Transfer Offices (TTOs) and an Entrepreneurship Support Provider to deliver components of the Beyond the Lab: From Research to Venture six-month venture-building programme for researcher teams developing healthcare innovations.

Eligible Applicant Types

This call targets organisational applicants and consortia rather than individuals. Eligible applicant types, explicitly referenced or implied in the call text, include:

1. 1Technology Transfer Offices (TTOs) hosted by higher education institutions and research organisations (universities, research centres).
2. 2Entrepreneurship Support Providers such as venture builders, incubators, accelerators, innovation consultancies, and organisations specialised in venture creation and start-up support.
3. 3Consortia composed of at least two TTOs (representing higher education institutions or research organisations) plus one Entrepreneurship Support Provider.
4. 4Research organisations and higher education institutions acting as consortium partners via their TTOs.
5. 5Nonprofit entities or units embedded in universities/research organisations that operate TTO activities or entrepreneurship programmes may apply as part of the consortium.

Funding Type and Nature of Support

Primary funding mechanism:grant (cascade funding). The programme finances external delivery partners to run the Beyond the Lab activities. Support is a combination of monetary funding to selected consortia and substantial non-monetary programme delivery responsibilities (live masterclasses, structured mentoring, Pitch Day organisation). Selected beneficiaries will therefore receive both financial resources (grant to deliver the programme) and contract-based service delivery responsibilities.

Consortium Requirement and Composition

Consortium requirement:mandatory. The call specifically requests a consortium made up of two Technology Transfer Offices plus one Entrepreneurship Support Provider. The two TTO partners should each represent a higher education institution or research organisation. The Entrepreneurship Support Provider must demonstrate experience in venture building and start-up support. The combined consortium should hold complementary capabilities covering intellectual property management, technology transfer, researcher engagement, venture building, business model development, market validation, investment readiness, and start-up growth experience.

Beneficiary Scope (Geographic Eligibility)

The call is issued by EIT Health under a Horizon/EIT framework and is targeted at organisations operating within the EIT Health network and the European context. Geographic eligibility is therefore oriented to EU Member States and associated countries typically eligible under Horizon/EIT activities. The scraped text does not list explicit third countries or exclusions; applicants should verify precise eligible country lists in the official call documents. For registration applicants must obtain a Participant Identification Code (PIC) on the EU Funding & Tenders Portal.

Target Sector and Thematic Focus

Sector:health and healthcare innovation. Thematic focus: bridging academic research and venture creation in healthcare technologies and innovations. Activities to be delivered include researcher-focused venture building, commercialization readiness, IP and technology transfer support, market validation, business model development, investor readiness, and Pitch Day events to showcase cohort ventures.

Project Stage and Expected Outcomes

Target project maturity of participating researcher teams:late research / pre-company formation through early venture creation. The programme supports teams who have identified company formation as their next step and need support to transform research outputs into incorporated start-ups. Expected outcomes for participant teams by programme end: incorporation of start-ups, progressed commercialisation strategy and product development, improved investment readiness and stronger position for follow-on funding and scale-up.

Mentioned Countries

No specific countries are explicitly listed in the scraped content. The geographic frame is European (EIT Health / Horizon) and therefore generally relevant to EU Member States and Horizon-associated countries. Applicants should consult the official call documentation for exact eligible country lists and any restrictions.

Funding Amount and Budgeting

Total budget available for the call is €154,000. The call text does not provide a per-award or per-consortium award amount or the number of consortia to be funded. Applicants should consult the official call documents for details on the distribution of the total budget, eligible costs, fee structure for service delivery, and payment schedules. The funding is presented as cascade funding to external delivery partners.

Application Type and Submission Process

Application type:open competitive call with a single-stage submission. Applicants must first register their organisation in the EU Funding & Tenders Portal to obtain a PIC. Step 2 requires submission through EIT Health’s application platform (applicants click Apply via EIT Health platform). The call is open for organisations to apply; applicants can submit separate applications for different EIT Health Bootcamp learning paths if they have capacity and expertise to deliver multiple paths.

Submission and Evaluation Stages

The selection and evaluation pipeline consists of the following stages:admissibility and eligibility check; online pitching with Q&A; an Ethical, Legal and Social Issues (ELSI) review for shortlisted proposals; and final selection and contracting. Each application is scored by evaluation panel members, comprising three external independent experts and up to two EIT Health subject matter experts. Final scores are the mean of reviewers' scores out of 100. Only applications scoring at least 70/100 are eligible for funding consideration.

1. 1Admissibility and Eligibility Check: formal verification by EIT Health staff according to call requirements (see chapters 3.1 through 3.4 in the official call documents).
2. 2Online Pitching: invited applicants deliver a pitch and answer questions in a live session. Each panel member evaluates the written application, the pitch, and the Q&A responses. Applicants must be available at the assigned pitching date/time; rescheduling is not guaranteed.
3. 3Ethical, Legal and Social Issues (ELSI) Review: independent experts review shortlisted proposals to assess ethical, legal and social considerations and de-risk EIT Health portfolio.
4. 4Final Selection Notification and Contracting: EIT Health management takes the final funding decision based on scores, expert recommendations and available budget. Applicants scoring below 70/100 are not considered for funding. If a top-ranked applicant fails contracting, next eligible applicants scoring at least 70/100 may be approached.

Application Stages Count

Applicants must pass through four main stages to receive funding:1) Admissibility and eligibility check; 2) Online pitching; 3) ELSI review; 4) Final selection and contracting.

Success Rates

The scraped opportunity details do not specify success rate statistics or the number of consortia to be funded. Given the fixed total budget (€154,000) and typical cascade funding practice, competition may be strong; however, exact success rate is not provided and should be considered unknown. Applicants should plan for a competitive selection.

Co-funding Requirement

The public call text provided does not explicitly state a co-funding requirement for applicants. The presence or absence of co-funding obligations, eligible cost rules, and the percentage of costs covered by the grant should be verified in the official call documentation and the financial rules annex. Applicants should consult the official call documents and any budget templates provided by EIT Health for precise co-financing rules.

Application Templates and Required Contents (Structure Guidance)

The scraped text provides procedural steps but does not include the full application form. Based on the call description and normal EIT Health cascade-call practice, applicants should prepare the following structured content and appendices when applying via EIT Health platform:

1. 1Consortium description: legal names, PIC numbers, roles and responsibilities of each partner, evidence of the required consortium composition (two TTOs + one Entrepreneurship Support Provider).
2. 2Organisational capacity and relevant experience: evidence of prior venture building, TTO outputs, incubator/accelerator delivery, mentoring and pitch-event organisation, references and CVs of key personnel.
3. 3Programme delivery plan: detailed workplan and timeline covering the six-month Beyond the Lab programme components, number of cohorts to be supported (two cohorts over two years as described), live masterclass syllabus, mentoring structure, and Pitch Day delivery plan.
4. 4Target participant profile and recruitment plan: description of how researcher teams will be recruited and assessed for programme suitability, diversity and geographic reach approach.
5. 5Intellectual Property and Technology Transfer approach: processes for IP assessment and management, researcher engagement, and handover to company formation.
6. 6Impact and KPIs: measurable indicators (expected number of teams incorporated, milestones achieved, investment readiness metrics, follow-on funding targets, participant satisfaction, jobs created).
7. 7Budget and financial plan: detailed budget lines, cost justification, proposed fees for service delivery, any requested grant amount, and explanation of how the consortium will use the funding to deliver programme activities.
8. 8Ethics and ELSI considerations: description of ethical, legal and social issues relevant to proposed delivery, data protection, participant consent where applicable, and mitigation measures (to support the ELSI review).
9. 9Risk management: identification of key risks, mitigation strategies and contingency plans for participant recruitment, delivery modality (in-person vs online), and partnership risks.
10. 10Supporting documents: organisation registration documents, PIC confirmation, letters of commitment or intent from consortium partners, CVs of trainers and mentors, previous project references.

Applicants must prepare and submit their application through EIT Health’s application platform after obtaining or confirming their PIC on the EU Funding & Tenders Portal. Separate applications are required per Bootcamp learning path if applying to more than one.

Evaluation and Scoring Details

Evaluation panel composition:three external independent experts plus up to two EIT Health subject matter experts. Scoring: each evaluator scores the combined submitted application, pitch and Q&A; final score is the arithmetic mean of reviewers' scores, out of 100. Minimum score threshold for funding consideration: 70/100. Applicants will receive feedback from each expert.

Other Practical Requirements and Notes

1. 1Applicants must be registered and have a PIC on the EU Funding & Tenders Portal.
2. 2Applicants must accept the assigned pitching date/time if invited; pitch slots are not guaranteed to be rescheduled.
3. 3Applicants may apply for multiple learning paths but must submit separate applications for each.
4. 4Applicants should attend the information session (09 September 2026) and the Q&A session (15 October 2026) to clarify requirements and expectations.
5. 5The ELSI review is mandatory for projects suggested for funding and may affect final selection.

For full legal and administrative requirements, eligibility conditions, and the formal application template, applicants should consult the official call document and supporting documents linked from the EIT Health opportunity page and the EU Funding & Tenders Portal Official call and supporting documents. ¹

Summary and practical explanation

This opportunity is a targeted cascade funding call run by EIT Health to contract external delivery partners to run the Beyond the Lab: From Research to Venture programme. The call seeks a consortium composed of two Technology Transfer Offices from higher education or research organisations plus one Entrepreneurship Support Provider to jointly deliver live masterclasses, mentoring and Pitch Day events for researcher teams aiming to form healthcare start-ups. The total allocation for the call is €154,000 and the contracted delivery partners will be engaged for 24 months to run two cohorts over two years. The selection process is competitive and single-stage: applicants register on the EU portal (PIC), submit via EIT Health’s platform, pass an admissibility check, may be invited to an online pitch and Q&A, undergo an ELSI review if shortlisted, and must achieve at least 70/100 to be considered for funding. The call blends monetary grant support for consortium delivery with significant non-monetary obligations (providing training, mentoring, and events). Interested consortia should prepare a detailed consortium description, delivery workplan, budget, evidence of institutional and practical experience in technology transfer and venture creation, and ethics/ELSI documentation, and should attend the scheduled information and Q&A sessions to clarify requirements.

Footnotes

1. 1Official call documents, guidance and registration links are available on the EU Funding & Tenders Portal and the EIT Health opportunity page. Applicants must consult those documents for precise eligibility, budget allocation per award, eligible cost rules and templates.

EIT Health is inviting a consortium made up of two Technology Transfer Offices and one Entrepreneurship Support Provider to deliver components of the Beyond the Lab: From Research to Venture programme, a six month venture building programme for researchers developing promising healthcare innovations.[1][3]

Opportunity summary

What the funding supports

The call supports delivery of entrepreneurship and venture building activities that help research teams turn healthcare innovations into incorporated start ups, including masterclasses, mentoring and a final Pitch Day.[1][3]

The opportunity sits within EIT Health’s 2026 to 2028 Business Plan, which is positioned around accelerating healthcare innovation, strengthening Europe’s health ecosystem and linking innovation, education and entrepreneurship.[13][15]

Who can apply

The call is aimed at consortia rather than single applicants, specifically requiring two TTOs, typically based in universities or research organisations, together with one Entrepreneurship Support Provider such as a venture builder, incubator, accelerator or innovation consultancy with demonstrated venture building and start up support experience.[1]

• Applicants should be able to demonstrate relevant capacity in technology transfer, entrepreneurship support and venture building.[1]
• The lead organisation must register in the EU Funding and Tenders Portal to obtain a PIC number before applying.[1]
• Applications are submitted through the EIT Health application platform after portal registration.[1]
• Invited applicants must be available for the assigned online pitching session, because pitch slots cannot be rearranged to suit applicant availability.[1]

Funding and duration

Funding available:The call provides up to €77000 in 2027 and up to €77000 in 2028, for a total envelope of €154000, with an expected participation period of 24 months.[1]

Public grant listings also describe the scheme as covering up to 50 percent of costs, with the remaining share to be co funded, although that funding rate detail is not visible in the short official portal snippet.[8][11][12]

How proposals are assessed

1. 1Admissibility and eligibility check by EIT Health staff against the call conditions.[1]
2. 2Online pitching with a presentation and question and answer session, evaluated by three external independent experts and up to two EIT Health subject matter experts.[1]
3. 3Ethical, Legal and Social Issues review by independent experts to confirm that critical ethical, legal and social considerations are properly addressed.[1]
4. 4Final ranking and funding decision by EIT Health management based on expert recommendations, scores and available funding.[1]
5. 5Only proposals scoring at least 70 out of 100 can be considered for funding, and the final score is the mean of the reviewers’ scores.[1]

Key dates and applicant notes

• Call opening date: 02 September 2026.[1][3]
• Call closing date: 02 November 2026.[1][3]
• Eligibility notification is scheduled for 06 November 2026.[1]
• Top ranked applications are invited to contracting, and if a selected applicant does not proceed to contract the next highest ranked proposal scoring at least 70 out of 100 may be contacted.[1]
• All applicants receive outcome notifications and feedback from the experts after the process.[1]

Practical assessment for applicants

The strongest applications are likely to combine proven technology transfer expertise, credible venture building delivery capacity, and a well structured partnership between two TTOs and one entrepreneurship support provider.[1]

Because the call is tied to a specific programme delivery role rather than general research activity, applicants should align their proposal closely with the Beyond the Lab: From Research to Venture format and show that they can deliver the activities within the 24 month window.[1][3]